Introduction {#s1}
============

Mass spectrometry (MS)-based identification of the components of purified protein complexes has become one of the most powerful and routinely used technologies for high-throughput detection of protein interactions [@pone.0018690-Mann1], [@pone.0018690-Lin1]. The study of protein interactions by MS for identification of components of protein complexes gives powerful insights into protein function, binding partners and cellular pathways [@pone.0018690-Patterson1], [@pone.0018690-Ranish1]. In most studies, proteins in a given complex are identified via MS analysis of in-gel tryptic digests of electrophoretically separated proteins of particular sub-cellular fractions (membranes, nuclei, intracellular compartments) or in co-immunoprecipitated complexes [@pone.0018690-Husi1], [@pone.0018690-Grant1], [@pone.0018690-Walsh1], [@pone.0018690-Carrascal1].

CD4 is the main cellular receptor used by human immunodeficiency viruses HIV-1, HIV-2 and simian immunodeficiency virus [@pone.0018690-Sattentau1], [@pone.0018690-Dalgleish1], [@pone.0018690-Maddon1]. It is a type I transmembrane glycoprotein of 55 kDa expressed on the surface of Regulatory and Helper subsets of T lymphocytes and interacts with MHC class-II carrying cells [@pone.0018690-Doyle1]. CD4 increases the avidity of the low affinity interactions between the peptide-MHC complex on antigen presenting cells and the T cell receptor on the lymphocyte, and its association with the intracellular protein tyrosine kinase LCK modulates signal transduction [@pone.0018690-Veillette1]. In humans and rats CD4 is also expressed on cells of the monocyte/Mφ lineage, although its function on these cells is poorly understood, and the protein expression levels are 10- to 20-fold less than in T cells [@pone.0018690-Lynch1], [@pone.0018690-Collman1]. In lymphoid cells expressing LCK, 90% of CD4 is restricted to the cell surface and undergoes limited internalization [@pone.0018690-PelchenMatthews1]. Endocytosis of CD4 can occur, through clathrin-coated pits, when the cytoplasmic domain becomes serine phosphorylated, leading to its dissociation from LCK [@pone.0018690-PelchenMatthews2], [@pone.0018690-PelchenMatthews3], [@pone.0018690-Pitcher1]. In myeloid cells, such as Mφ, which do not express LCK, CD4 is constitutively internalized and 40--50% is intracellular at steady-state [@pone.0018690-PelchenMatthews1]. The pathways by which CD4 is removed from the cell surface and the protein-network involved are poorly defined. Cell surface CD4 levels can be down-regulated by exposure to gangliosides [@pone.0018690-Garofalo1], soluble HIV-1 gp120 [@pone.0018690-Karsten1], phorbol esters [@pone.0018690-PelchenMatthews2], [@pone.0018690-Hoxie1] and during HIV-1 infection [@pone.0018690-Tanaka1], [@pone.0018690-PelchenMatthews4]. Moreover, down-regulation of viral receptors is a common mechanism used by most retroviruses to avoid superinfection (multiple rounds of infection) and to promote viral release. HIV-1 Nef protein accelerates CD4 internalization and degradation in the lysosomes [@pone.0018690-Chaudhuri1], and at the late stages of HIV-1 infection, CD4 can be targeted for proteasomal degradation by HIV-1 Vpu [@pone.0018690-Levesque1], [@pone.0018690-Schubert1], [@pone.0018690-Jin1].

Most reports to date have analysed CD4 interaction complexes in lymphoid cell lines, revealing some of the well-known associating proteins, such as LCK, CD45, transferrin receptor (CD71), CD98, myosins, vimentin, tubulins, actins, annexin II and lymphocyte phosphatase associated phosphoprotein (LPAP) [@pone.0018690-Bernhard1], [@pone.0018690-Bernhard2], [@pone.0018690-Bernhard3], [@pone.0018690-Krotov1]. However, little is known about how CD4 antigen is arranged at the surface of Mφ, which notably lack LCK expression.

In common with other laboratories we found that the kinetics of HIV-1 replication was modulated by the simultaneous presence of Mφ and T cells in different ratios and activation states [@pone.0018690-Khati1], [@pone.0018690-Porcheray1], [@pone.0018690-ZollaPazner1]. Data from our laboratory reported that HIV-1 viral production was typically slower in infected cultures in which Mφ were co-cultured with activated T cells. More recently, we extended these observations and showed that activated T cells produce soluble factors that selectively induce the internalization and degradation of CD4 in primary Mφ, thus critically affecting HIV-1 entry in a process sensitive to the vacuolar ATPase inhibitor bafilomycin A1, and the proteasomal inhibitor, MG132 (Saraiva Raposo et al., manuscript under revision).

In this report we perform high-resolution mass spectrometry analysis of CD4 co-immunoisolates in human primary Mφ, in order to characterise the CD4 containing complexes in steady-state and at different stages of CD4 internalization and degradation. The experimental strategy is shown in [Fig. 1](#pone-0018690-g001){ref-type="fig"}.

![Strategy for the identification of CD4-complexes in human primary Mφ.\
CD14^+^ monocytes were isolated from human blood by magnetic cell sorting (MACS) and cultured for 7 days in the presence of M-CSF. One hundred million day 7 fully differentiated Mφ were left untreated (Condition 1, blue), treated with conditioned media from activated T cells (Induced CD4 internalization and degradation, Condition 2 red) or treated with conditioned media from activated T cells in the presence of the proteasomal inhibitor MG132 and the inhibitor of vacuolar ATPases bafilomycin (BafA1) (Induced CD4 internalization but blocked degradation, Condition 3 green). Eighteen hours later, cells were detached from tissue culture plates, lysed and large-scale anti-CD4 immunoprecipitations (IP) using monoclonal antibody against CD4 (clone QS4120) or isotype control IP were carried out. IP products were loaded onto SDS-PAGE pre-cast gels and electrophoresis were run. Protein gels were coomassie stained, gel lanes were cut into 10 equal pieces and trypsin-digested. Proteins were identified by LC-MS/MS.](pone.0018690.g001){#pone-0018690-g001}

Results {#s2}
=======

Conditioned media from activated T cells induces CD4 internalization and degradation in Mφ {#s2a}
------------------------------------------------------------------------------------------

In order to effectively demonstrate the induction of CD4 internalization and degradation, we detected the expression of CD4 in Mφ before and after treatment with conditioned media from activated T cells by flow cytometry. Eighteen hours post-treatment the expression of CD4 levels at the surface of Mφ was barely detectable ([Fig. 2A](#pone-0018690-g002){ref-type="fig"}), and the percentage of Mφ expressing surface CD4 was significantly reduced by 4-fold ([Fig. 2B](#pone-0018690-g002){ref-type="fig"}). In addition, total CD4 expression (surface + intracellular) was diminished by 2-fold ([Fig. 2C](#pone-0018690-g002){ref-type="fig"}). Altogether, these data suggest the internalization and degradation of CD4 after treatment with conditioned supernatants from activated T cells.

![CD4 is internalized and degraded after treatment with conditioned media from activated T cells.\
Mφ were treated with conditioned media from activated T cells for 18 hours or left untreated, followed by flow cytometry staining with directly conjugated mAb to CD4. **A** Black histogram represents the appropriate isotype control. Histograms show the intensity of the signal on the X-axis with a log~10~-scale and the percentage of maximum expression on the Y-axis. Representative staining of more than five donors tested (n\>5). **B** Bars represent the mean percentage of Mφ expressing surface CD4 with SD error bars from ten independent donors (n = 10). **C** Total CD4 expression levels (surface + intracellular) were determined by dividing the geometrical MFI of the antibody staining over the MFI of the isotype control. Bars represent the mean values of five independent donors (n = 5) with SD error bars. In **B** and **C**, black bar corresponds to untreated Mφ and white bar corresponds to conditioned media treated Mφ (T cell Sup).](pone.0018690.g002){#pone-0018690-g002}

Anti-CD4 co-immunoprecipitation sub-proteome in control Mφ {#s2b}
----------------------------------------------------------

We performed large-scale CD4 immunoprecipitations in normal resting primary human Mφ, followed by LC-MS/MS. A representative gel of the resolved proteins after CD4 co-immunoisolation is shown in [Fig. 3](#pone-0018690-g003){ref-type="fig"}. In control resting Mφ (condition 1), several cell surface proteins associated with CD4 were identified, including CD9, a tetraspanin-family member involved in cell adhesion, cell motility and IL-16 signalling [@pone.0018690-Qi1], [@pone.0018690-KuritaTaniguchi1], [@pone.0018690-Kaji1], [@pone.0018690-Jolly1]; CD163, involved in the clearance and endocytosis of hemoglobin/haptoglobin complexes [@pone.0018690-Buechler1], [@pone.0018690-Kristiansen1]; integrin subunit beta (CD18), involved in cell surface adhesion and reported to interact with integrins alpha-M and alpha-X [@pone.0018690-Law1]; protein S100, a calcium binding protein known to be involved in phagocyte migration and infiltration at sites of wounding [@pone.0018690-Bode1]; chemokine receptor 1 (CCR-1), a G protein-coupled receptor [@pone.0018690-Gao1]; adaptor protein 2 (AP-2), a known adaptor protein which functions in protein transport via transport vesicles in different membrane trafficking pathways [@pone.0018690-Chaudhuri1], [@pone.0018690-Sorkin1], and HLA class I, involved in antigen presentation [@pone.0018690-Schaefer1]. CD4 was also found to be associated with cytoskeleton and actin-modulating proteins, such as gelsolin, tropomyosins and dynein. An unknown and uncharacterised protein, TPP1 was also identified. A summary list of interacting proteins is shown in [table 1](#pone-0018690-t001){ref-type="table"}.

![Representative protein gels of anti-CD4 immunoprecipitations in Mφ.\
Mφ were left untreated (Condition 1, blue), treated with conditioned media from activated T cells (Condition 2, red) or treated with conditioned media from activated T cells in the presence of 5 µM of MG132 and 100 nM of BafA1 (Condition 3, green). Eighteen hours later, cells were lysed and anti-CD4 immunoprecipitations were carried out. The final immunoisolates were resuspended in Laemmli sample buffer under reducing and denaturing conditions, before loading onto a SDS-PAGE pre-cast gel. Isotype control IgG immunoprecipitations were also performed to show non-specific background binding proteins.](pone.0018690.g003){#pone-0018690-g003}

10.1371/journal.pone.0018690.t001

###### Uniquely identified proteins in anti-CD4 co-immunoprecipitations in control Mφ (Condition 1).

![](pone.0018690.t001){#pone-0018690-t001-1}

  PROTEIN NAME                                      GENE     MOLECULAR WEIGHT   LOCALIZATION           FUNCTION/STRUCTURE           UNIPROT ACCESSION   PROBABILITY   UNIQUE PEPTIDES
  ----------------------------------------------- --------- ------------------ -------------- ------------------------------------ ------------------- ------------- -----------------
  Gelsolin, isoform 2                                GSN          80,641        Cytoskeleton        Actin-modulating protein             P06396              1              14
  Tropomyosin alpha-3 chain, isoform 2              TPM3          29,033        Cytoskeleton        Actin-modulating protein             P06753              1               6
  Integrin beta 2                                   ITGB2         84,782          Membrane               Cell adhesion                   P05107              1               5
  Golgi autoantigen (Golgin), subfamily A2         GOLGA2        113,086           Golgi              cis-Golgi structure                Q08379              1               4
  Tropomyosin alpha 4 chain, isoform 1              TPM4          28,522        Cytoskeleton        Actin-modulating protein             P67936              1               4
  Putative uncharacterized protein TPP1             TPP1          60,369          Unknown                   Unknown                      B5MDC1              1               4
  Coatomer, subunit gamma                           COPG          97,718         Cytoplasm             Protein transport                 Q9Y678              1               3
  Cytoplasmic dynein 1, heavy chain 1              DYNC1H1       532,408        Microtubules             Motor protein                   Q14204              1               3
  Hematopoietic lineage cell-specific protein       HCLS1         53,984          Membrane        Antigen receptor signalling            P14317              1               3
  AP-2 complex subunit beta, isoform 1              AP2B1        104,553          Membrane             Protein transport                 P63010              1               3
  Protein S100-A9                                  S100A9         13,242          Membrane                 Chemotaxis                    P06702              1               3
  Actin-related protein 2/3 complex, subunit 1B    ARPC1B         40,950         Cytoplasm               Actin binding                   O15143              1               2
  Actin-related protein 2/3 complex, subunit 4      ARPC4         19,667         Cytoplasm               Actin binding                   P59998              1               2
  F-actin capping protein, subunit beta             CAPZB         37,482         Cytoplasm               Actin binding                   B4DWA6              1               2
  Scavenger receptor (M130) cysteine-rich           CD163        125,437          Membrane        Scavenger-receptor activity            Q86VB7              1               2
  HLA class I histocompatibility antigen            HLA-C         36,798          Membrane            Antigen presentation               Q29960           0.9998             2
  Protein S100-A8                                  S100A8         10,835          Membrane                 Chemotaxis                    P05109              1               2
  Ras-related C3 botulinum toxin substrate 2        RAC2          21,429         Cytoplasm                GTP binding                    P15153              1               2
  Tropomyosin 1 alpha chain, isoform 2              TPM1          32,678        Cytoskeleton        Actin-modulating protein             Q9Y427           0.9996             2
  C-C chemokine receptor type 1                     CCR1          41,173          Membrane     G-protein coupled receptor protein        P32246           0.9888             2
  CD9 antigen                                        CD9          25,416          Membrane                 Signalling                    P21926           0.9952             2

Protein and gene names, molecular weight in Daltons, cellular localization, function/structure, Uniprot accession number, protein identification probability from iProphet and unique number of identified peptides for each individual protein are shown.

Anti-CD4 co-immunoprecipitation sub-proteome in induced internalization and degradation {#s2c}
---------------------------------------------------------------------------------------

Internalization and degradation of CD4 in Mφ was induced by conditioned media from activated T cells (condition 2) and interacting proteins were identified by CD4 co-immunoprecipitation followed by LC-MS/MS. A representative gel of the resolved proteins after CD4 co-immunoisolation is shown in [Fig. 3](#pone-0018690-g003){ref-type="fig"}. Proteins identified included Cdc42, a small GTPase family protein involved in signal transduction and endocytosis [@pone.0018690-Georgiou1], [@pone.0018690-Izumi1]; proteins associated with late endocytic trafficking, such as LAMP1, a component of the lysosomal membrane [@pone.0018690-Cook1], [@pone.0018690-Kannan1]; RhoB, known to be associated with the late endosome membrane; adaptor protein 1 (AP-1), a subunit of clathrin-associated adaptor protein complex 1 [@pone.0018690-Sorkin1], [@pone.0018690-Chi1], [@pone.0018690-Camus1]; Sec23B, a component of coating protein II (COPII) involved in the transport of vesicles from the Golgi apparatus to the endoplasmic reticulum, and Rab10/Rab11B, important components of vesicle recycling and protein turn-over [@pone.0018690-Sorkin1], [@pone.0018690-Ullrich1]. Several cytoplasmic and cytoskeleton-related proteins were also identified, including fascin, myosin and tensin. Annexin A2, a calcium regulated membrane binding protein and flotillin-1, a scaffolding protein associated with caveolar membranes [@pone.0018690-Glebov1] were also identified with more than 5 unique peptides. A complete list of the uniquely identified proteins is shown in [table 2](#pone-0018690-t002){ref-type="table"}.

10.1371/journal.pone.0018690.t002

###### Uniquely identified proteins in anti-CD4 co-immunoprecipitations in induced CD4 internalization and degradation in Mφ (Condition 2).

![](pone.0018690.t002){#pone-0018690-t002-2}

  PROTEIN NAME                                      GENE    MOLECULAR WEIGHT       LOCALIZATION       FUNCTION/STRUCTURE    UNIPROT ACCESSION   PROBABILITY   UNIQUE PEPTIDES
  ----------------------------------------------- -------- ------------------ ---------------------- --------------------- ------------------- ------------- -----------------
  Actin, cytoplasmic 2                             ACTG1         41,793            Cytoskeleton          Actin binding           P63261           0.9993            11
  Annexin A2, isoform 1                            ANXA2         38,604              Membrane           Calcium binding          P07355              1               9
  Alpha actinin 4                                  ACTN4        104,854             Cytoplasm              Transport             O43707              1               6
  Flotillin 1                                      FLOT1         47,355              Membrane          Protein transport         O75955           0.99775            6
  Protein transport protein, Sec23B                SEC23B        86,479           COPII Vesicle        Protein transport         Q15437              1               5
  Integrin beta                                    ITGB2         78,345              Membrane            Cell adhesion           A8MYE6           0.99825            3
  Fascin                                           FSCN1         54,530             Cytoplasm            Actin binding           Q16658              1               2
  Myosin-Va, isoform 1                             MYO5A        215,405             Cytoplasm            Actin binding           Q9Y4I1              1               2
  Tensin 3, isoform 1                               TNS3        155,266             Cytoplasm           Protein binding          Q68CZ2           0.9955             2
  Cytosolic non-specific dipeptidase, isoform 2    CNDP2         43,833             Cytoplasm             Proteolysis            Q96KP4              1               2
  Reticulon 4, isoform 2                            RTN4         40,318              Membrane           Protein binding          Q9NQC3              1               2
  Ras-related protein, Rab-10                      RAB10         22,541              Membrane          Protein transport         P61026           0.99775            2
  Ribonuclease inhibitor                            RNH1         49,973             Cytoplasm           Protein binding          P13489              1               2
  Cell division control protein 42, Isoform 1      CDC42         21,311         Cytoplasm/Membrane        GTP binding            P60953           0.9955             2
  AP-1 complex subunit beta 1, Isoform A           AP1B1        104,637        Clathrin Coated Pits       Endocytosis            Q10567           0.9955             2
  Lysosome associated membrane glycoprotein 1      LAMP1         44,882              Lysosome         Protein degradation        P11279           0.9955             2
  Ras-related protein, Rab-11B                     RAB11B        24,489              Membrane          Protein transport         Q15907           0.9965             2
  Rho-related GTP-binding protein, RhoB             RHOB         22,123              Membrane          Protein transport         P62745           0.9876             2

Protein and gene names, molecular weight in Daltons, cellular localization, function/structure, Uniprot accession number, protein identification probability from iProphet and unique number of identified peptides for each individual protein are shown.

Anti-CD4 co-immunoprecipitation sub-proteome in induced internalization and blocked degradation {#s2d}
-----------------------------------------------------------------------------------------------

In condition 3, internalization of CD4 in Mφ was induced by the same conditioned media from activated T cells, as described for condition 2, and cellular degradation was blocked using the proteasome inhibitor MG132 and the vacuolar ATPase inhibitor bafilomycin A1. CD4-interacting proteins were identified by co-immunoprecipitations followed by LC-MS/MS. A representative gel of the resolved proteins after CD4 co-immunoisolation is shown in [Fig. 3](#pone-0018690-g003){ref-type="fig"}. CD4 was associated with a large number of proteins related to protein degradation, in particular the proteasome. Proteasome-related proteins such as the 26S regulatory subunit 6B, ubiquitin-like modifier activating enzymes E1 and E3 ubiquitin protein ligase subunit Itch [@pone.0018690-Shembade1], [@pone.0018690-Chang1], [@pone.0018690-Gallagher1], [@pone.0018690-Gao2] were identified. Proteins associated with antigenic presentation and intracellular protein trafficking were also identified, such as MHC-I molecules (HLA-A and HLA-B), ERp29 and ERp1 (endoplasmic reticulum chaperones) [@pone.0018690-Meunier1]. Although identified with one unique peptide, but with high iProphet probability scores, we also detected 7 proteins, including components of vacuolar proton-transporting ATPases, such as V-type proton ATPase subunits D and G1. A complete list of the uniquely identified proteins is shown in [table 3](#pone-0018690-t003){ref-type="table"}.

10.1371/journal.pone.0018690.t003

###### Uniquely identified proteins in anti-CD4 co-immunoprecipitations in induced CD4 internalization and blocked degradation in Mφ (Condition 3).

![](pone.0018690.t003){#pone-0018690-t003-3}

  PROTEIN NAME                                           GENE     MOLECULAR WEIGHT         LOCALIZATION                 FUNCTION/STRUCTURE            UNIPROT ACCESSION   PROBABILITY   UNIQUE PEPTIDES
  --------------------------------------------------- ---------- ------------------ -------------------------- ------------------------------------- ------------------- ------------- -----------------
  Heat shock 70 kDa protein 1/2                         HSPA1B         70,052               Cytoplasm               Chaperone, protein folding             P08107              1              19
  Coronin 1C                                            CORO1C         49,379              Cytoskeleton                 Signal transduction                B4DMH3              1               3
  Heme oxygenase 1                                      HMOX1          32,819                   ER                         Metal-binding                   P09601              1               3
  Guanine nucleotide-binding protein G, isoform 2       GNAI2          38,473                Membrane            GTP Binding, signal Transduction          P04899              1               3
  Annexin IV                                            ANXA4          36,085               Cytoplasm                     Calcium binding                  Q6LES2              1               2
  Annexin VI                                            ANXA6          75,277               Cytoplasm                     Calcium binding                  A6NN80           0.7873             2
  Endoplasmic reticulum protein, ERp29                  ERP29          28,993                ER lumen             Intracellular protein transport          P30040              1               2
  Guanine nucleotide-binding protein subunit beta 4      GNB4          37,567               Cytoplasm                Transmembrane signalling              Q9HAV0           0.9989             2
  HLA class I histocompatibility antigen                HLA-A          40,892                Membrane           Antigen processing and presentation        P16190              1               2
  Hypoxia up-regulated protein 1                        HYOU1         111,335                ER lumen               Chaperone, protein folding             Q9Y4L1              1               2
  E3 ubiquitin-protein ligase Itchy, isoform 1           ITCH         102,803               Cytoplasm                 Protein ubiquitination               Q96J02              1               2
  Heterogeneous nuclear ribonucleoprotein R             HNRNPR         70,943               Cytoplasm                     mRNA processing                  O43390           0.9931             2
  Ras-related protein Rab-1A                            RAB1A          22,678                Membrane                    Protein transport                 P62820           0.9898             2
  Endoplasmic reticulum aminopeptidase 1, isoform 2     ERAP1         107,841                ER lumen           Antigen processing and presentation        Q9NZ08              1               2
  Ras-related protein, Rab-1B                           RAB1B          22,171                Membrane                    Protein transport                 Q9H0U4           0.9898             2
  26S protease regulatory subunit 6B                    PSMC4          47,366           Proteasome Complex              Protein degradation                P43686           0.9971             2
  Proteasome activator complex, subunit 1               PSME1          28,723           Proteasome Complex              Protein degradation                Q06323           0.9971             2
  Proteasome subunit alpha type 4                       PSMA4          29,484           Proteasome Complex              Protein degradation                P25789           0.9971             2
  Ubiquitin-like modifier-activating enzyme 1            UBA1         117,849                Cytosol               Ubiquitin conjugation pathway           P22314           0.9971             2
  Antigen peptide transporter 1                          TAP1          87,218                ER lumen                    Protein transport                 Q03518           0.9971             1
  HLA class I histocompatibility antigen                HLA-B          40,481                Membrane           Antigen processing and presentation        P30481           0.9971             1
  Tyrosine-protein phosphatase non-receptor             PTPN6          67,561               Cytoplasm                   Signal transduction                P29350           0.9778             1
  Ras-related protein, Rab-14                           RAB14          23,897                Membrane                    Protein transport                 P61106           0.9971             1
  Transmembrane emp24 domain-containing protein         TMED10         24,976        Golgi apparatus membrane      Vesicular protein trafficking           P49755           0.9971             1
  V-type proton ATPase subunit D                       ATP6V1D         28,263                Vacuole                Proton-transporting ATPase             Q9Y5K8           0.9971             1
  V-type proton ATPase subunit G1                      ATP6V1G1        13,758                Vacuole                Proton-transporting ATPase             O75348           0.9969             1

Protein and gene names, molecular weight in Daltons, cellular localization, function/structure, Uniprot accession number, protein identification probability from iProphet and unique number of identified peptides for each individual protein are shown.

[Table 4](#pone-0018690-t004){ref-type="table"} lists the proteins commonly identified in all three conditions.

10.1371/journal.pone.0018690.t004

###### Proteins commonly identified in all conditions.

![](pone.0018690.t004){#pone-0018690-t004-4}

  PROTEIN NAME                                       GENE     MOLECULAR WEIGHT      LOCALIZATION              FUNCTION/STRUCTURE           UNIPROT ACCESSION   PROBABILITY   UNIQUE PEPTIDES
  ----------------------------------------------- ---------- ------------------ --------------------- ----------------------------------- ------------------- ------------- -----------------
  Myosin 9, isoform 1                                MYH9         226,532             Cytoplasm                  Actin binding                  P35579              1              126
  Ras GTPase-activating-like protein                IQGAP1        189,252             Membrane           Ras GTPase activator activity          P46940           0.99954           40
  Major vault protein                                MVP           99,327             Cytoplasm                Protein transport                Q14764              1              35
  Filamin A, isoform 2                               FLNA         280,018           Cytoskeleton                Protein binding                 P21333              1              34
  Vimentin                                           VIM           53,652              Cytosol                   Actin binding                  P08670              1              28
  Plastin 2                                          LCP1          70,289             Cytoplasm                  Actin binding                  P13796              1              22
  Clathrin heavy chain 1                             CLTC         191,615        Clathrin coated pit           Protein transport                Q00610              1              20
  Protein transport protein, Sec16A                 SEC16A        233,517             ER/Golgi                 Protein transport                O15027           0.99478           19
  Endoplasmin                                      HSP90B1         92,469              Cytosol              ERAD protein catabolism             P14625           0.99998           13
  Alpha actinin 1                                   ACTN1         103,058           Cytoskeleton                 Actin binding                  P12814              1              11
  Talin 1                                            TLN1         269,767           Cytoskeleton                 Actin binding                  Q9Y490           0.9996            11
  Moesin                                             MSN           67,820           Cytoskeleton                 Cell adhesion                  P26038              1              10
  DnaJ subfamily C member 10                       DNAJC10         91,080             ER lumen                  Protein folding                 Q8IXB1           0.9977             9
  CD4 antigen                                        CD4           51,111             Membrane                 Receptor activity                P01730           0.99942            9
  Protein transport protein, Sec24C                 SEC24C        118,325           COPII vesicle             ER/Golgi transport                P53992           0.95185            8
  Annexin A5                                        ANXA5          35,937             Cytoplasm                 Calcium binding                 P08758           0.9988             7
  Profilin 1                                         PFN1          15,054           Cytoskeleton                 Actin binding                  P07737           0.99954            7
  Protein disulfide isomerase                        P4HB          57,116             Membrane            Protein disulfide isomerase           P07237           0.99735            6
  V-type proton ATPase, subunit B                  ATP6V1B2        56,501              Cytosol            Proton-transporting ATPase            P21281           0.99883            6
  Calreticulin                                       CALR          48,142              Cytosol                  Calcium binding                 P27797           0.9984             5
  Cathepsin B                                        CTSB          37,822             Lysosome         Degradation/turn-over of proteins        P07858           0.99787            5
  Coronin 1A                                        CORO1A         51,026           Cytoskeleton                 Actin binding                  P31146           0.99748            5
  Cofilin 1                                          CFL1          18,502           Cytoskeleton                 Actin binding                  P23528           0.9987             4
  F-actin-capping protein, subunit alpha 2          CAPZA2         32,949           Cytoskeleton                 Actin binding                  P47755           0.9966             4
  Protein transport protein, Sec24A                 SEC24A        119,749           COPII Vesicle             ER/Golgi transport                O95486           0.99903            4
  Myeloid cell nuclear differentiation antigen       MNDA          45,836             Cytoplasm            Transcription regulation             P41218           0.99806            4
  Transferrin receptor protein 1                     TFRC          84,871             Membrane           Transferrin receptor activity          P02786           0.9967             4
  14-3-3 protein zeta/delta                         YWHAZ          27,745              Cytosol                Signal transduction               P63104           0.99913            3
  Integrin alpha M                                  CD11b         127,179             Membrane                   Cell adhesion                  P11215           0.99747            3
  Protein-glutamine gamma-glutamyltransferase 2      TGM2          77,329             Membrane                   Cell adhesion                  P21980           0.99808            3
  Lymphocyte-specific protein 1                      LSP1          37,192             Membrane                Signal transduction               P33241           0.99903            3
  Macrophage-capping protein                         CAPG          38,518              Cytosol                   Actin binding                  P40121           0.99758            3
  Ras-related protein, Rap-1b                       RAP1B          20,825             Membrane                  GTPase activity                 P61224           0.99743            3
  IgE Fc receptor subunit gamma                     FCER1G         9,667              Membrane                 Receptor activity                P30273           0.99773            2
  Protein S100-A11                                 S100A11         11,740              Cytosol                  Calcium binding                 P31949           0.99883            2

Protein and gene names, molecular weight in daltons, cellular localization, function/structure, Uniprot accession number, protein identification probability from iProphet and unique number of identified peptides for each individual protein are shown.

Western Blotting analysis of CD4 co-immunoprecipitates in Mφ {#s2e}
------------------------------------------------------------

Mass spectrometry identifications of CD9, E3 ubiquitin ligase Itch and clathrin heavy chain in CD4 co-immunoisolates were confirmed by western blot analysis. As anticipated, CD4 was identified in all Mφ sample conditions, but at reduced levels in condition 2. Clathrin heavy chain 1 was co-immunoisolated with CD4 in all three conditions and the E3 ubiquitin ligase subunit Itch was only co-immunoisolated with CD4 when cellular degradation was blocked. CD9 antigen was only co-immunoisolated with CD4 in the control Mφ. CCR5, reported to interact with CD4 at the surface of Mφ and T cells [@pone.0018690-Xiao1], was not identified by mass spectrometry in any of the conditions described above and was not detected by western blot analysis of CD4 co-immunoisolates ([Fig. 4](#pone-0018690-g004){ref-type="fig"}).

![Western blot analysis of CD4 co-immunoprecipitates in Mφ.\
A total of 1×10^7^ Mφ were left untreated (Condition 1, blue), treated for 18 hours with supernatants from activated T cells (Condition 2, red), treated for 18 hours with supernatants from activated T cells in the presence of 5 µM MG132 and 100 nM BafA1 (Condition 3, green), lysed and anti-CD4 immunoprecipitation reactions were carried out. Isotype control immunoprecipitations were also performed to show background protein binding. Immunoisolates were resuspended in Laemmli sample buffer under reducing and denaturing conditions and resolved on a SDS-PAGE gel. Membranes were incubated with antibodies against CD4, clathrin heavy chain (HC) 1, E3 Ubiquitin (Ub) ligase Itch, CD9 and CCR5. Primary antibodies were detected and scanned using the quantitative western blotting imaging Odyssey System. A representative blot of three different blood donors is shown (n = 3).](pone.0018690.g004){#pone-0018690-g004}

GO annotations {#s2f}
--------------

Uniquely identified protein identifications in all three conditions were exported to ProteinCenter and GO annotations were carried out. In induced CD4 internalization and degradation (condition 2) there is an over-representation of proteins associated with the endosome, vacuole and Golgi, when compared to control Mφ (condition 1). Moreover, when cellular degradation is blocked (condition 3) the over-represented CD4-associated proteins are related to the proteasome, endoplasmic reticulum, organelle lumen, mitochondrion and cytosol ([Fig. 5A](#pone-0018690-g005){ref-type="fig"}). Proteins related to DNA and nucleotide-binding are over-represented in condition 3 and metal binding proteins are over-represented in condition 2. No proteins with structural molecular activities were uniquely identified in condition 3, in contrast to control or condition 2, where 30% and 15%, respectively, of the uniquely identified proteins fall into this category ([Fig. 5B](#pone-0018690-g005){ref-type="fig"}). Proteins related to cell organization and biogenesis, cell differentiation, development and transport are greatly over-represented in condition 2 over condition 3. In control Mφ, proteins related to response to stimulus and defence response are over-represented over the other two. Cell motility-related proteins cluster with CD4 in control Mφ and in condition 2 ([Fig. 5C](#pone-0018690-g005){ref-type="fig"}).

![Gene Ontology (GO) annotations of the uniquely identified proteins in anti-CD4 immunoprecipitations in Mφ.\
Protein identifications from the three different conditions were exported from the in-house developed Central Proteomics Facilities data analysis pipeline (CPFP) and uploaded to ProteinCenter software. **A** illustrates the percentage of protein identifications versus protein cellular localizations (GO cellular annotations); **B** illustrates the percentage of protein identifications versus protein molecular functions (GO molecular annotations) and **C** illustrates the percentage of protein identifications versus protein biological functions (GO biological annotations). Blue bars represent the percentage of unique proteins identified in condition 1 (Resting macrophages); Red bars represent the percentage of unique proteins identified in condition 2 (Induced CD4 internalization and degradation); Green bars represent the percentage of unique proteins identified in condition 3 (Induced CD4 internalization and blocked degradation).](pone.0018690.g005){#pone-0018690-g005}

Discussion {#s3}
==========

Mass spectrometry analysis of CD4 co-immunoisolates, supplemented with GO annotations provided useful information on the clustering of CD4 molecules in resting Mφ and elucidated the protein-network involved in the internalization and degradation. CD4 in resting Mφ showed association with a range of molecules found in the cellular cortex and membrane rafts. Consistent with earlier reports [@pone.0018690-Pitcher1], [@pone.0018690-Chaudhuri1], [@pone.0018690-Faure1], we also observed CD4 association, and confirmed by western blotting, with components of clathrin-mediated endocytosis, such as clathrin heavy chain 1 and the adaptor protein AP-2, clearly suggesting that in resting Mφ CD4 undergoes constitutive internalization and recycling [@pone.0018690-PelchenMatthews1], [@pone.0018690-PelchenMatthews3], [@pone.0018690-PelchenMatthews5]. AP-2 has been reported to be involved in the initial formation of clathrin coated pits at the plasma membrane, and it is an important mediator of receptor internalization and clathrin assembly [@pone.0018690-Rappoport1]. We observed CD4 association with the tetraspanin protein CD9, and as both CD4 and CD9 are able to bind IL-16 in mast cells [@pone.0018690-Qi1], [@pone.0018690-GrazianiBowering1], this association might in fact be physiologically relevant in Mφ.

In addition to CD4, HIV-1 requires CXCR4 or CCR5 to enter target cells. Xiao et al., reported a constitutive cell surface association between CD4 and CCR5 [@pone.0018690-Xiao1] and showed that the presence of gp120, leads to the clustering of CD4 and CCR5. However, they stated that it was difficult to co-immunoisolate CD4 and CCR5 in human primary Mφ and CD4^+^ T cells in the absence of gp120, arguing that the levels of both receptors were very low and the techniques used were not sensitive enough. Employing high-resolution mass spectrometry analysis on a large sample of primary Mφ, a more sensitive technique than the one used by Xiao et al., we did not detect CCR5 molecules in CD4 co-immunoisolates. Although a constitutive CD4-CCR5 interaction in the absence of gp120 might still exist, our results do not support this notion.

Many reports to date have shown that in CD4^+^ T cells LCK binds directly to the cytoplasmic tail of CD4 [@pone.0018690-Veillette1], [@pone.0018690-PelchenMatthews1], [@pone.0018690-PelchenMatthews3], providing stability at the cell surface. As we did not identify any Src family protein kinases in CD4 co-immunoisolates in Mφ, it seems unlikely that this kinase family plays a similarly prominent role in the regulation of CD4 in Mφ, as it does in T cells. This could also explain the faster turn-over of CD4 in Mφ compared to T cells.

Data from our laboratory showed that upon treatment with conditioned media from activated T cells, CD4 expression in Mφ is down-regulated due to induced internalization and degradation (Saraiva Raposo et al., manuscript under revision). Under this condition, CD4 was associated with specific components of signal transduction and transport pathways, including plasma membrane-associated small GTPases, such as Cdc42, Ras-related proteins and RhoB. The small GTPases of the Ras superfamily are well known to have roles in endocytosis [@pone.0018690-Ellis1], [@pone.0018690-Qualmann1]. RhoB regulates endosomal trafficking, in co-operation with mDia1 and Src kinase [@pone.0018690-Ridley1], and Cdc42, which has also been connected to cell migration and cell polarity, has also been linked to the regulation of endocytosis [@pone.0018690-Kroschewski1]. We observed an interaction between CD4 and LAMP1, suggesting the intervention of lysosomes in the down-regulation of CD4. This observation correlates with the effect induced by the phorbol ester PMA in the induction of CD4 internalization and degradation [@pone.0018690-Petersen1]. Overall, the over-representation of endosome-related proteins in this condition, clearly clusters CD4 with the endocytic pathways.

When Mφ are treated with conditioned media from activated T cells in the presence of MG132 and bafilomycin A1, CD4 can still be internalized, but it is not degraded (Saraiva Raposo et al. manuscript under revision). Under this condition, CD4 was associated with several components of the proteasome, such as regulatory and activating subunits involved in the cascade of protein ubiquitination, suggesting the involvement of the proteasomal pathway. We identified the member of the E3 ubiquitin (Ub) ligase family, Itch/AIP4 to be associated with CD4 and confirmed it by western blot. Itch is a member of the HECT domain-containing E3 Ub ligases and has been implicated in the post-translational modification with Ub of CXCR4, followed by desensitization at the cell surface by engagement to its cognate ligand SDF-1α [@pone.0018690-Liu1].

In the early stages of HIV-1 infection, the viral protein HIV-1 Nef, reported to accelerate CD4 down-regulation, avoiding viral superinfection and promoting efficient viral spread and optimal viral particle production [@pone.0018690-Chaudhuri1], also alters the intracellular trafficking of MHC-I and MHC-II molecules [@pone.0018690-Schwartz1]. HIV-1 Nef-dependent reduction of surface MHC-I protects HIV-infected primary T cells from recognition and killing by HIV-specific cytotoxic T cells in vitro [@pone.0018690-Collins1]. Schaefer et al. reported that HIV-1 Nef targets MHC-I molecules and CD4 for degradation in the lysosomes, by showing co-localization of CD4 and a subset of HLA-A2 proteins in late endosomes and multi-vesicular bodies (MVB) [@pone.0018690-Schaefer2]. We showed an interaction between CD4 and components of MHC-I (HLA-A and HLA-B). Although, our system is an HIV-1 Nef-independent system, both induced pathways seem to have some degree of similarity.

Overall in resting macrophages CD4 shows association with a range of proteins found in the cellular cortex, clathrin coated pits and membrane rafts. In induced internalization the spectrum of proteins clustered with the receptor changes and CD4 becomes associated with components of signal transduction and transport. Finally, under conditions where protein degradation pathways are chemically blocked, CD4 associates with components of the proteasome and ubiquitin-modifying proteins.

This is the first co-immunoisolation LC-MS/MS-based identification of CD4 complexes in human primary Mφ elucidating CD4-interacting proteins and the protein-network involved in its induced internalization and degradation. Due to its importance in the context of HIV-1 infection, revealing the CD4 "interactome" can lead to the discovery of important proteins in the pathogenesis of the virus. In conclusion, our mass spectrometry data contribute to a better understanding of the fate of CD4 molecules in resting Mφ and in induced internalization and degradation.

Materials and Methods {#s4}
=====================

Ethics statement {#s4a}
----------------

Adult human blood was obtained from anonymous donors through the UK National Blood Service and tested negative for HIV-1, hepatitis B/C, and syphilis. Local IRB approval was sought for this work from Oxford University\'s Central University Research Ethics Committee (CUREC), and we were informed that specific ethical approval was unnecessary for this study, in accordance with their guidelines on the use of human blood (<http://www.admin.ox.ac.uk/curec/resrchapp/faqethapp.shtml>): "CUREC does not require an ethics form for laboratory research using buffy coats. However there are occasions when the National Blood Service donating the buffy coats may require ethical approval from the University. In this instance a checklist completion will suffice. Applicants should answer Question C (8) as a 'NO'. A covering note should be sent to the Secretary of the MSD IDREC with the checklist explaining that the research uses buffy coats and the NBS requires University ethical approval." Although not required by NBS, we completed a checklist as indicated and received exemption from MSD IREC.

Cells and reagents {#s4b}
------------------

PBMC were isolated using Ficoll-Plaque Plus (GE Healthcare Life Sciences, Europe) density gradient centrifugation from heparinized buffy-coats. Monocytes were isolated by CD14-positive selection using anti-CD14 magnetic beads (Miltenyi Biotec, UK), according to the manufacturer\'s instructions and seeded in complete medium (RPMI 10% FCS (PAA), 2 mM L-glutamine (PAA), 100 U/mL penicillin (PAA) and 100 µg/mL streptomycin (PAA)), supplemented with 50 ng/mL recombinant M-CSF (R&D Systems) for 7 days. MG132 and bafilomycin A1 (BafA1) (Sigma, UK) were resuspended in DMSO (Sigma, UK) and used at final non-toxic concentrations of 5 µM and 100 nM, respectively. CD4^+^ T Helper cells were isolated from the CD14-negative population of PBMC, by negative selection (Miltenyi Biotec, UK), according to the manufacturer\'s protocol and activated using anti-biotin MACSiBead particles and biotinylated antibodies against human anti-CD2, CD3 and CD28 (Miltenyi Biotec, UK) in complete medium for 3 days. Cell-free supernatants were collected after 3 days stimulation, filtered (0.45 µm pore-size) and stored until used. Typically, day 7 fully differentiated Mφ were treated with neat T cell supernatants, in the absent or presence of MG132 and BafA1 for 18 hours, prior to CD4 co-immunoisolation.

Flow cytometry {#s4c}
--------------

CD4 expression levels were detected by direct immunofluorescence. Mφ in staining buffer (10 µg/mL human IgG (Sigma UK), 1% FCS and 0.01% NaN~3~) were incubated with 5 µg/mL anti-CD4 specific mAb (clone RPA-T4, Becton Dickinson) or matched isotype control (IgG1κ, Becton Dickinson) on ice for 30--45 min. For intracellular staining, cells were first fixed, then permeabilized with 0.2% saponin (Sigma, UK) and stained. The percentage of positive cells and the mean fluorescence intensity (MFI) were analyzed by FACS Calibur (Becton Dickinson) with 15,000**--**20,000-gated events collected. The data was processed using FlowJo (version 7.2.4). Protein expression levels were determined by dividing the geometrical MFI of the Ab staining over the MFI of the isotype control.

Western blotting {#s4d}
----------------

Adherent Mφ were washed free of media, detached using ice cold 10 mM EDTA/PBS and cell pellets were lysed in ice-cold lysis buffer (50 mM Tris-HCl pH 8, 150 mM NaCl, 1% (v/v) n-Dodecyl β-D-maltoside (Sigma), 1× protease inhibitor cocktail (Roche), phosphatase inhibitor cocktail 2 (Sigma)). n-Dodecyl β-D-maltoside is a water-soluble non-ionic detergent, shown to be a rather gentle detergent able to preserve protein activity and structure better than many commonly used agents, such as Triton X-100, NP-40, CHAPs and octyl-β-glucoside [@pone.0018690-leMaire1], [@pone.0018690-Banerjee1], [@pone.0018690-Harder1], [@pone.0018690-Thomas1]. Lysates were centrifuged for 10 min at 4°C, 13,000×g to separate insoluble material and cleared lysate was resuspended in 1× Laemmli sample buffer (Invitrogen, UK) under reducing conditions and heated for 10 min at 90°C. Lysates were electrophoresed through SDS--PAGE gels and proteins were electroblotted to PVDF transfer membranes. Blocked membranes were incubated with one of the following primary antibodies diluted in 3% (w/v) BSA (Sigma) in 1× PBS-T (1× PBS, 0.1% (v/v) Tween-20) for 2 hours at room temperature or over-night at 4°C: rabbit polyclonal antibody anti-CD4 (clone H-370), rabbit polyclonal antibody anti-CD9 (clone H-110), rabbit polyclonal antibody anti-clathrin heavy chain 1 (clone H-300), rabbit polyclonal antibody anti-E3 Ubiquitin ligase (clone H-110) (all from Santa Cruz) and mouse monoclonal antibody anti-CCR5 (clone CTC5, R&D Systems). Primary antibodies were detected using the matching LI-COR secondary antibodies and membranes were scanned using the quantitative western blotting imaging system Odyssey (LI-COR).

Immunoisolation analysis {#s4e}
------------------------

Anti-CD4 immunoisolation reactions consisted of 10 µL of protein G--Sepharose bead slurry (4B Fast Flow, Sigma, UK) per 1×10^7^ lysed cells and 5--10 µg mouse monoclonal antibody anti-CD4 (clone QS4120, Santa Cruz) was incubated for 2 hours at room temperature to allow binding of the antibody to the beads. Beads were gently spun, cell lysate was added to the mixture of beads/antibody and the reactions were incubated by inversion for 3 hours at 4°C. The immunoisolates were collected by centrifugation for 5 min at 4°C, and washed three times for 5 min with lysis buffer. The final immunoisolates were resuspended in Laemmli sample buffer under reducing conditions and heated for 10 min at 90°C, before loading them onto a gel. Isotype control immunoprecipitations were also performed to identify background binding proteins.

Mass spectrometry and protein identification {#s4f}
--------------------------------------------

Anti-CD4 or isotype control immunoisolated pellets were reduced in NuPAGE sample reducing agent (Invitrogen, UK), separated on a NuPAGE Novex 4--12% Bis-Tris gel (Invitrogen, UK) and coomassie stained. Gel lanes were excised, cut into 10 equal portions and in-gel digested with trypsin [@pone.0018690-Shevchenko1]. Briefly, gel bands were diced into cubes and destained in 25 mM ammonium bicarbonate in 50∶50 water/acetonitrile. Proteins were reduced with 10 mM DTT and alkylated with 55 mM iodoacetamide. Gel bands were then incubated with 3 µg of trypsin (Promega, UK) in 25 mM ammonium bicarbonate over-night at 37°C. Peptides were extracted and desalted using home-made C18 tips. Mass spectrometry data were acquired on an Orbitrap mass spectrometer (Thermo) fitted with a nanospray source (Proxeon, Denmark) coupled to a U3000 nano HPLC system (Dionex, UK). The samples were loaded onto a 15 cm long, 100 micron ID, home-packed column manufactured by packing a Picotip emitter (New Objective, USA) with ProntoSIL C18 phase; 120 angstrom pore, 3 micron bead, C18 (Bischoff Chromatography, Germany). HPLC was run in a direct injection configuration. One hundred and twenty minute gradients were used to resolve the peptides. The Orbitrap was run in a data dependent acquisition mode in which the Orbitrap resolution was set at 60,000 and the top 5 multiply charged precursors were selected for MS/MS fragmentation. Samples were typically injected three times in order to increase the number and confidence of identifications. RAW data files were converted to mzXML format using ReAdW (version 4.2.1) and submitted to the in-house developed Central Proteomics Facilities Pipeline (CPFP) [@pone.0018690-Trudgian1]. The CPFP is based on the Trans Proteomic Pipeline tools (version 4.2.1) [@pone.0018690-Keller1] and implements automatic identification of MS/MS spectra using multiple search engines to maximise coverage of a sample. mzXML files were converted to suitable peaklist formats for submission to Mascot (Matrix Science), X!Tandem with k-score plugin [@pone.0018690-MacLean1] and OMSSA [@pone.0018690-Geer1]. Searches are performed automatically and executed on a compute cluster, using Sun GridEngine, and the resulting peptide identifications from each search engine are validated with PeptideProphet [@pone.0018690-Keller2]. iProphet is used to combine peptide hits from each three search engines and refines identification probabilities. ProteinProphet infers protein identifications from the resulting combined peptide list and performs grouping of ambiguous hits [@pone.0018690-Nesvizhskii1]. Protein identifications were exported from the CPFP and uploaded to ProteinCenter (Proxeon, Denmark) for filtering, annotation, classification, and interpretation. Searches were performed against a concatenated target/decoy human IPI database providing an empirical false discovery rate (FDR) and criteria for protein identification included 1% FDR and two or more unique peptides identified for each individual protein. Proteins that were identified in the isotype control immunoprecipitations were filtered out of the final interpretation. Uniquely identified proteins were only identified in the condition tested and commonly identified proteins were identified in all conditions tested.

Statistical analysis {#s4g}
--------------------

Statistical analysis was performed by paired t-test using GraphPad Prism (version 5.01). Stars indicate the p-value: \*\*p = 0.01-0.001; \*\*\*p\<0.001. Significance refers to difference from the controls, unless otherwise indicated. N refers to the number of blood donors tested.
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